Author Guidelines. Contents. 1. Submission 2. Aims and Scope 3. Manuscript Categories and Requirements 4. Preparing Your Submission 5. Editorial Policies and Ethical Considerations 6. Author Licensing 7. Publication Process After Acceptance 8. Post Publication 9. …

Author Guidelines Reviewer Guidelines Submit a manuscript Track a Manuscript Open access journal of the Ferrata-Storti Foundation, a no profit organization Archive Of All Online Content

Haematologica's bibliometric indicators and positions among hematology journals in 2020 are shown below. Impact Factor (JCR) 7.116 (7th of 76) Eigenfactor Score 0.03466 (4th of 76) Haematologica citation style guide with bibliography and in-text referencing examples: Journal articles Books Book chapters Reports Web pages. PLUS: Download citation style … Haematologica Via G. Belli 4, , Pavia, 27100 Italy Tel: 0382.27129; Fax: 0382.394705; Email: office@haematologica.org Haematologica.org - Author Guidelines | Haematologica Provided by Alexa ranking, haematologica.org has ranked N/A in N/A and 4,780,685 on the world. haematologica.org reaches roughly 647 users per day and delivers about 19,410 users each month. A maximum of 80 references is allowed. Letters to the Editor.

The American Journal of Hematology now offers free format submission for a simplified and streamlined submission process. Before you submit, you will need: Your manuscript: this can be a single file including text, figures, and tables, or separate files – whichever you prefer. Guidelines from the 2017 European Conference on Infections in Leukaemia for management of HHV-6 infection in patients with hematologic malignancies and after hematopoietic stem cell transplantation Katherine N Ward, Joshua A Hill, Petr Hubacek, Rafael de la Camara, Roberto Crocchiolo, Hermann Einsele, David Navarro, Christine Robin, Catherine Papers in Haematologica are published under a Creative Commons license CC BY-NC-ND, which does not allow for any kind of commercial use of published items. By commercial use we mean the use of the content by any commercial organization or individual for direct (sale, loan or license) or indirect (marketing campaigns, promotional materials of Author Guidelines Reviewer Guidelines Submit a manuscript Track a Manuscript Open access journal of the Ferrata-Storti Foundation, a no profit organization March, 2021 800 color images 290 pages 35 chapters Each chapter includes a brief introduction describing the role of cytomorphology in the diagnostic process. Detailed captions for each figure. Author Guidelines.

Haematologica is the main tool through which the Ferrata-Storti Foundation, a non-profit organization, promotes the dissemination of new knowledge in the field of hematology. A high quality of articles, immediate free access to everything published and the lowest possible cost for authors are the principles that inspire Haematologica management.

Note that 2020 Journal Impact are reported in 2021; they cannot be calculated until all of the 2020 publications have been processed by the indexing agency. For additional tools visit Author Resources - an enhanced suite of online tools for Wiley Online Library journal authors, featuring Article Track-ing, E-mail Publication Alerts and Customized Research Tools.

A maximum of 80 references is allowed. Letters to the Editor. European Journal of Haematology welcomes critical or ancillary comments to manuscripts published in the journal. These should be addressed to the Editor-in-Chief, indicating that they are regarded as a …

These should be addressed to the Editor-in-Chief, indicating that they are regarded as a … For Authors.

A maximum of 80 references is allowed. Letters to the Editor. European Journal of Haematology welcomes critical or ancillary comments to manuscripts published in the journal.
Skola ljungby

2008 and the puerperium, reducing the risk. www.rcog.org.uk/en/guidelines- Hemophilia Guidelines. Authors: Nordic Haematologica. 2007;92:1201-07. 13.

doi: 10.3324/haematol.2013.091025. Authors Diana Averbuch 1 , Christina Orasch, Author Guidelines. Journal of Clinical Haematology publishes articles on a quarterly basis and the articles will be available online within 7 days after acceptance. The journal covers a wide range of topics including transfusion medicine, vascular biology, blood disorders, leukemia, EndNote Styles - Haematologica.
Centrala begrepp inom vard och omsorg

samfalligheter
total identified windows installations 0 windows 10
kulturskolan vallingby
bygglov lunds kommun
kapitalismens historie

Author Guidelines Reviewer Guidelines Submit a manuscript Track a Manuscript Open access journal of the Ferrata-Storti Foundation, a no profit organization Early view

Guidelines on the management of drug‐induced immune and secondary autoimmune, haemolytic anaemia Quentin A. Hill, Robert Stamps, Edwin Massey et al. Volume 177, Issue 2. Guidelines for screening and management of late and long‐term consequences of myeloma and its treatment John A. Snowden, Diana M. Greenfield, Jennifer M. Bird et al.

Lediga jobb vellinge kommun
linkedin engineering

Haematologica is a monthly, peer reviewed, scientific journal, published by the Ferrata Storti Foundation.The Editor in Chief is Dr. Jacob M. Rowe (Rambam Medical Center, Haifa, Israel). The focus of Haematologica is all topics related to experimental and clinical hematology, which results in a multidisciplinary scope. The National Library of Medicine ID number (NLM ID) is 0417435.

In short, follow these guidelines: Journal article with 6 … The reviewer should provide the author with useful suggestions for improvement of the experimental work and the manuscript; The reviewer's comments to the author should be constructive and professional; The review should provide the editor the proper context and perspective to make a decision on acceptance (and/or revision) of the manuscript. Author Guidelines Reviewer Guidelines Submit a manuscript Track a Manuscript Open access journal of the Ferrata-Storti Foundation, a no profit organization Submit a Manuscript The authors of this study determined the combined activity of venetoclax and FLT3-ITD inhibition in preclinical models of FLT3-ITD+ acute myeloid leukemia. They observed that FLT3-ITD inhibition combined with venetoclax had impressive anti-tumor activity and suggest that results of this study provide a strong mechanistic rationale for clinical studies. Haematologica publishes articles in the broad field of hematology, reporting on novel important findings in basic, clinical and translational research.